FLGT News and Press, Fulgent Genetics Inc. From 08/27/20

Cocrystal Pharma (NASDAQ: COCP )   -25%  after raising "bought deal" offering to $15M. More news on: Cocrystal Pharma, Inc., SunPower Corporation, Quidel Corporation, Stocks on the move, , Read more ...

We always very much liked Fulgent Genetics ( FLGT ). For the old portfolio we bought it at $9.87 in November last year . We particularly liked the fact that competitors outsource some of their testing to Fulgent, a tell-tale sign that they're doing something right. The CEO Ming Hsoeh is somet...

As a result of increased capacity from the newly launched CLIA-certified laboratory in Houston, Fulgent Genetics ( FLGT -2.0% ) raises FY20 revenue guidance to $135M from the previous $120M. More news on: Fulgent Genetics, Inc., Stocks on the move, Healthcare stocks news, Read mo...

CLIA-Certified Laboratory will Increase Testing Capacity Raising FY20 Revenue Guidance to $135 Million from $120 Million TEMPLE CITY, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a te...

Healthcare spending is one part of the economy, guaranteed to keep rising due to the aging population. The coronavirus will also lead to a boost in investment in the sector. SRNE, IRTC, and FLGT are lesser-known healthcare stocks that should be on your radar. The overall backdrop has been ...

Image source: The Motley Fool. Fulgent Genetics, Inc. Common Stock   (NASDAQ: FLGT) Q2 2020 Earnings Call Aug 04, 2020 , 4:30 p.m. ET Operator Continue reading

Fulgent Genetics, Inc. (FLGT) Q2 2020 Earnings Conference Call August 4, 2020 4:30 PM ET Company Participants Nicole Borsje - Head, IR Ming Hsieh - Chief Executive Officer Paul Kim - Chief Commercial Officer Brandon Perthuis - Chief Commercial Officer Conference Call Parti...

Fulgent Genetics (NASDAQ: FLGT ) : Q2 Non-GAAP EPS of $0.17 beats by $0.19 ; GAAP EPS of $0.14. More news on: Fulgent Genetics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Second Quarter 2020 Results : Record Revenue of $17.3 million, growing 105% year-over-year Record Billable tests delivered total 180,513, growing 1003% year-over-year Gross Margin improved approximately 8 percentage points from Q1 2020; cost per test improved approximately 81% year-o...

Biotech Pulse Biotechs continue to be one of the leading healthcare groups and along with diagnostics represent two of the best segments of healthcare. The first half saw biotechs recover quicker from the March selloff than most of the market, and reach a milestone that took 5 years to achie...